CLOCK and neoplasm: The dysfunction of circadian clock genes is associated with tumor malignancy (Katamune et al., 2019; Katamune et al., 2016; Masri et al., 2015); hence, activation of clock function can be a therapeutic strategy for treatment of cancers.